Ionis's Tryngolza Achieves Landmark Success in Severe Triglyceride Treatment
Ionis Pharmaceuticals' experimental drug olezarsen significantly reduced triglycerides and pancreatitis events in a study, leading to a nearly 33% stock increase and plans to seek FDA approval this year, marking a major breakthrough in hypertriglyceridemia treatment.